- Home
- VERO vs INM Comparison
VERO vs INM Comparison
Compare VERO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERO | INM |
|---|---|---|
| Founded | N/A | 1981 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VERO | INM |
|---|---|---|
| Price | $1.87 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.1K | ★ 893.9K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,876,000.00 | $4,798,116.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.65 | $1.13 |
| 52 Week High | $14.50 | $8.27 |
Technical Indicators
Market Signals| Indicator | VERO | INM |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 46.19 |
| Support Level | $1.84 | $1.28 |
| Resistance Level | $1.99 | $1.52 |
| Average True Range (ATR) | 0.12 | 0.11 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 44.78 | 75.00 |
Price Performance
Historical ComparisonAbout VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.